A potencialidade dos lentivetores na terapia gênica / The potentiality of lentivectors in gene therapy

Os lentivírus, bem como os oncovírus e os spumavírus, pertencem à família Retroviridae. Essa família possui genoma composto por duas fitas simples de RNA e enzima transcriptase reversa. Os vírus de imunodeficiência humana (HIV), felina (FIV) e simiana (SIV) são os representantes mais bem conhecidos dos lentivírus, devido aos seus efeitos patológicos. O genoma dos lentivírus apresenta uma organização mais complexa do que dos oncovírus e muitos dos seus processos moleculares já estão descritos OU já são conhecidos. Além disso, são capazes de infectar inclusive células quiescentes, características essa que se opõe ao tropismo dos oncovírus. Essas propriedades levaram ao desenvolvimento de vetores lentivirais para terapia gênica e a perspectiva do emprego terapêutico dos mesmos na clínica – por exemplo, para síndrome da imunodeficiência adquirida (SIDA). Uma série de modificações de engenharia genética no lentivetor baseado em HIV levou ao desenvolvimento do primeiro protocolo clínico de terapia gênica lentiviral contra a SIDA, nos EUA. Atualmente, existem vários protocolos clínicos com lentivetores em andamento, seguindo a tendência de empregá-los também em outras doenças.(AU)

Lentivirus, oncovirus and spumavirus belong to the Retroviridae family. The genome of this family is composed of two single strands of RNA and reverse transcriptase enzyme. The human, feline and simian immunodeficiency virus (HIV, FIV, SIV) are well known lentivirus in our society due to their pathological effects. The Lentiviral genome is more complex than the oncovira and much of its molecular mechanisms are already known. In addition, they are able to infect also quiescent cells, in opposition to oncovirus tropism. These properties lead to the development of gene therapy lentiviral vectors and to their possible therapeutic use at clinical level – acquired immunodeficiency syndrome (AIDS), for example. After intense genetic engineering, a HIV based lentivector was first used in a clinical trial in a gene therapy protocol for AIDS, in USA. Currently, there are several clinical trials in progress using lenviral vectors, following the tendency of evaluating their potential to treat many other diseases.(AU)

A retrospective search for bovine respiratory syncytial virus (BRSV) antigens in histological specimens by immunofluorescence and immunohistochemistry

Bovine respiratory syncytial virus (BRSV) has been only sporadically identified as a causative agent of respiratory disease in Brazil. This contrasts with frequent reports of clinical and histopathological findings suggestive of BRSV-associated disease. In order to examine a possible involvement of BRSV in cases of calf pneumonia, a retrospective search was performed for BRSV antigens in histological specimens submitted to veterinary diagnostic services from the states of Rio Grande do Sul and Minas Gerais. Ten out of 41 cases examined (24.4 percent) were positive for BRSV antigens by immunohistochemistry (IPX). Eight of these cases (19.5 percent) were also positive by indirect immunofluorescence (IFA), and 31 cases (75.6 percent) were negative in both assays. In the lungs, BRSV antigens were predominantly observed in epithelial cells of bronchioles and less frequently found in alveoli. In one case, antigens were detected only in the epithelium of the alveolar septae. The presence of antigen-positive cells was largely restricted to epithelial cells of these airways. In two cases, positive staining was also observed in cells and cellular debris in the exudate within the pulmonary airways. The clinical cases positive for BRSV antigens were observed mainly in young animals (2 to 12 month-old) from dairy herds. The main microscopic changes included bronchointerstitial pneumonia characterized by thickening of alveolar septae adjacent to airways by mononuclear cell infiltrates, and the presence of alveolar syncytial giant cells. In summary, the results demonstrate the suitability of the immunodetection of viral antigens in routinely fixed tissue specimens as a diagnostic tool for BRSV infection. Moreover, the findings provide further evidence of the importance of BRSV as a respiratory pathogen of young cattle in southeastern and southern Brazil.

O Vírus Respiratório Sincicial Bovino (BRSV) tem sido raramente identificado como agente etiológico de doença respiratória em bovinos no Brasil. Isso contrasta com freqüentes relatos clínicos e histopatológicos sugestivos de enfermidade associada ao BRSV. Com o objetivo de investigar o possível envolvimento do BRSV em casos de pneumonia em bovinos jovens, realizou-se uma pesquisa retrospectiva para antígenos do BRSV em cortes histológicos de materiais submetidos a quatro serviços de diagnóstico nos Estados do Rio Grande do Sul e Minas Gerais. Dez entre 41 casos examinados (24,4 percent) foram positivos para antígenos do BRSV por imunohistoquímica (IPX). Oito desses casos (19,5 percent) também foram positivos por imunofluorescência (IFA) e 31 casos (75,6 percent) foram negativos em ambos os testes. Nos pulmões, antígenos virais foram detectados predominantemente nas células epiteliais dos bronquíolos e menos freqüentemente nos alveólos. Em um caso, antígenos virais foram detectados exclusivamente no epitélio alveolar. A presença de células positivas restringiu-se ao epitélio dessas vias aéreas. Em dois casos, antígenos virais foram detectados em células descamativas e em restos celulares no exsudato das vias aéreas. Os casos positivos para antígenos do BRSV eram oriundos principalmente de animais jovens (2 a 12 meses de idade) de rebanhos leiteiros. As principais alterações histológicas observadas foram pneumonia bronco-intersticial caracterizada por espessamento dos septos alveolares adjacentes às vias aéreas, infiltrados de células mononucleares e presença de células gigantes multinucleadas nos alveólos. Os resultados obtidos demonstram a utilidade dos métodos de detecção de antígenos em cortes histológicos para o diagnóstico da infecção pelo BRSV. Além disso, esses resultados confirmam evidências anteriores sobre a importância do BRSV como patógeno respiratório no sudeste e sul do Brasil.

The hamster (Mesocricetus auratus) as experimental model in chagas'diseases: parasitological and histopathological studies in acute and chronic phases of trypanosoma cruzi infection

This research characterizes the acute and chronic phases of Chagas'disease in hamster through parasitological and histopathological studies. The acute phase was achieved with 44 young hamsters injected intraperitoneally with 100.000 blood trypomastigotes of Benedito and Y strains of T. cruzi. The chronic phase was induced in 46 hamsters injected intraperitoneally with 35.000 trypomastigotes of Vicentina, Benedito and Y strains. Animals were sacrificed at regular intervals of 24 hours of acute phase and from the 3rd to the 10th month of infection of chronic phase. In the acute phase, parasites were easily recovered from all animals and there was an inflammatory reaction characterized by mononuclear and polymorphous leukocyte infiltration of variable degree in the majority of tissues and organs, specially in lhe connective loose and fatty tissues, smooth muscle myocardium and skeletal muscle. In the chronic phase the lesions occurred in the same tissues and organs, but the inflammatory response was less severe and characterized by mononuclear infiltration mainly with focal or zonal fibrosis in the myocardiun. In 50 per cent of infected animals parasites were found in myocardiun and recovered from pericardic, peritoneal and ascitic fluids in some animals. Signs of heart failure, sudden death and enlargement of bowel were observed regularly. We concluded that the hamster is an useful model for Chagas' disease studies.